SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.

TSXV:SQD.H - Post by User

SQI Diagnostics Inc > Grant of Options SEDI activity

<< Previous

Bullboard Posts

Next >>

Comment by 25Stone7859on Jun 09, 2021 11:58am

98 Views

Post# 33355279

RE:Grant of Options SEDI activity

Brouwer was granted 750,000 Options on 5/27/2021 @ $0.22. This was filed on 6/9/2021 giving him a total of 3,059,933 Options. He did not execute the 750,000 as was stated. Curiously, Brouwer however does not have much "skin in the game" because he only owns 20,000 shares outright. Say at a cost of $0.30 per share, his liability is only $6,000 compared to the free ride from his Options and obviously the holdings held by the investing public. There are others at SQI whose interests are similarly not aligned with shareholders.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing